| - Industry | - Sector | - CEO | MSE Exchange | - ISIN |
| India Country | 32 Employees | - Last Dividend | 7 Aug 2026 Last Split | - IPO Date |
Jojo Ltd. is a distinguished company operating within the healthcare sector, specifically in the pharmaceuticals and drugs industry. The company is deeply committed to the development, manufacturing, and distribution of pharmaceutical products that play a vital role in medical treatments and healthcare solutions. By maintaining a presence on stock exchanges, Jojo Ltd. offers investors an opportunity to engage with the dynamic pharmaceuticals segment, which is recognized for its innovation in drug formulation and therapeutic advancements.
The company boasts a significant promoter holding, which underscores its stable ownership structure and operational integrity. Founded in India, Jojo Ltd. is dedicated to addressing the essential needs in drug production and supply, thereby supporting both domestic healthcare demands and potential international health requirements. Its activities align with the growing importance of pharmaceutical advancements, thereby positioning the company as a crucial player in essential medical supply chains.
Jojo Ltd. specializes in the research and development of new pharmaceutical compounds, focusing on innovative drug formulation that meets the evolving needs of patients and healthcare providers. This includes studying the efficacy and safety of its products through rigorous clinical trials.
The company operates state-of-the-art manufacturing facilities that adhere to stringent regulatory standards. Jojo Ltd. produces a wide range of pharmaceutical products, ensuring high-quality production processes that cater to both local and international markets.
Jojo Ltd. has established an extensive distribution network that facilitates the timely delivery of its pharmaceutical products. This network ensures that healthcare providers and patients have access to the medications they need, when they need them, thereby supporting the overall healthcare ecosystem.
The company actively collaborates with hospitals, clinics, and other healthcare providers to enhance the effectiveness of its products. By working closely with medical professionals, Jojo Ltd. ensures its offerings are optimized for patient care and therapeutic success.
Jojo Ltd. places a strong emphasis on maintaining investor relations, providing transparency and insight into its operations and strategic initiatives. This approach helps cultivate investor confidence and fosters sustainable growth within the dynamic pharmaceuticals sector.